Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
32.85B | 32.23B | 29.45B | 28.95B | 26.13B | Gross Profit |
12.27B | 11.21B | 9.71B | 9.47B | 7.88B | EBIT |
5.07B | 4.87B | 3.34B | 5.72B | 1.59B | EBITDA |
6.13B | 5.83B | 4.34B | 6.83B | 2.47B | Net Income Common Stockholders |
3.94B | 3.75B | 2.48B | 4.55B | 345.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.64B | 5.82B | 4.88B | 5.33B | 5.39B | Total Assets |
40.36B | 40.94B | 39.15B | 40.26B | 41.09B | Total Debt |
7.81B | 8.74B | 8.55B | 6.48B | 7.12B | Net Debt |
3.50B | 4.85B | 4.39B | 2.32B | 3.84B | Total Liabilities |
25.30B | 26.79B | 25.88B | 24.30B | 25.09B | Stockholders Equity |
14.49B | 13.41B | 12.78B | 15.58B | 15.69B |
Cash Flow | Free Cash Flow | |||
3.83B | 3.52B | 525.00M | 2.51B | 999.00M | Operating Cash Flow |
4.67B | 4.29B | 1.29B | 3.33B | 1.69B | Investing Cash Flow |
-725.00M | -1.61B | 981.00M | 2.31B | 6.76B | Financing Cash Flow |
-3.33B | -2.90B | -2.39B | -4.97B | -8.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $25.79B | 52.77 | 22.29% | 0.18% | 16.74% | 9.28% | |
75 Outperform | $91.04B | 23.24 | 28.23% | 1.18% | 3.16% | 5.77% | |
71 Outperform | $7.41B | 18.17 | 17.86% | 0.26% | 2.78% | 11.53% | |
71 Outperform | $18.93B | 24.58 | 25.26% | 1.44% | 4.76% | 2.27% | |
66 Neutral | $8.21B | 25.28 | 8.73% | 1.54% | 0.78% | -41.54% | |
62 Neutral | $7.62B | 13.01 | 3.19% | 3.32% | 3.77% | -14.28% | |
59 Neutral | $4.07B | ― | -5.49% | ― | 10.53% | 90.76% |